RVL Pharmaceuticals plc Operating Cash Flow
RVL Pharmaceuticals plc reported Operating Cash Flow of -$17.88 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2023-08-14
- RVL Pharmaceuticals plc net cash provided by (used in) operating activities for the quarter ending 2023-06-30 was -$12.06M, a 704.31% decline year-over-year.
- RVL Pharmaceuticals plc net cash provided by (used in) operating activities for the quarter ending 2023-03-31 was -$5.82M.
- RVL Pharmaceuticals plc net cash provided by (used in) operating activities for the quarter ending 2022-12-31 was -$16.43M.
- RVL Pharmaceuticals plc net cash provided by (used in) operating activities for the quarter ending 2022-09-30 was -$10.10M.
- RVL Pharmaceuticals plc net cash provided by (used in) operating activities for fiscal 2022 was -$37.81M.
- RVL Pharmaceuticals plc net cash provided by (used in) operating activities for fiscal 2021 was -$54.73M, a 411.15% decline from fiscal 2020.
- RVL Pharmaceuticals plc net cash provided by (used in) operating activities for fiscal 2020 was $17.59M.
- RVL Pharmaceuticals plc net cash provided by (used in) operating activities for fiscal 2018 was $37.56M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | -$12.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$17.88M 10-Q · filed 2023-08-14 | -$34.31M derived: sum of 3 quarters · filed 2023-08-14 | -$44.41M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2023-03-31 | -$5.82M 10-Q · filed 2023-05-11 | -$22.25M derived: sum of 2 quarters · filed 2023-05-11 | -$32.35M derived: sum of 3 quarters · filed 2023-05-11 | -$30.35M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-12-31 | -$16.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | -$26.53M derived: sum of 2 quarters · filed 2023-03-20 | -$24.53M derived: sum of 3 quarters · filed 2023-08-14 | -$37.81M 10-K · filed 2023-03-20 | ||||
| 2022-09-30 | -$10.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$8.10M derived: sum of 2 quarters · filed 2023-08-14 | -$21.38M 10-Q · filed 2022-11-10 | -$45.77M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$11.28M 10-Q · filed 2023-08-14 | -$35.67M derived: sum of 3 quarters · filed 2023-08-14 | -$51.60M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$13.28M 10-Q · filed 2023-05-11 | -$37.67M derived: sum of 2 quarters · filed 2023-05-11 | -$53.60M derived: sum of 3 quarters · filed 2023-05-11 | -$56.52M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$24.39M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | -$40.32M derived: sum of 2 quarters · filed 2023-03-20 | -$43.25M derived: sum of 3 quarters · filed 2023-03-20 | -$54.73M 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | -$15.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$18.85M derived: sum of 2 quarters · filed 2022-11-10 | -$30.34M 10-Q · filed 2022-11-10 | -$38.59M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | -$2.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$14.41M 10-Q · filed 2022-08-11 | -$22.66M derived: sum of 3 quarters · filed 2022-08-11 | -$13.12M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | -$11.49M 10-Q · filed 2022-05-12 | -$19.74M derived: sum of 2 quarters · filed 2022-05-12 | -$10.20M derived: sum of 3 quarters · filed 2022-05-12 | $6.17M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$8.25M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $1.29M derived: sum of 2 quarters · filed 2022-03-30 | $17.65M derived: sum of 3 quarters · filed 2022-03-30 | $17.59M 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | $9.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $25.91M derived: sum of 2 quarters · filed 2021-11-15 | $25.84M 10-Q · filed 2021-11-15 | $26.52M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $16.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $16.30M 10-Q · filed 2021-08-16 | $16.98M derived: sum of 3 quarters · filed 2021-09-08 | $54.03M derived: sum of 4 quarters · filed 2021-09-08 | ||||
| 2020-03-31 | -$64.00K 10-Q · filed 2021-05-13 | $611.00K derived: sum of 2 quarters · filed 2021-09-08 | $37.66M derived: sum of 3 quarters · filed 2021-09-08 | $39.63M derived: sum of 4 quarters · filed 2021-09-08 | ||||
| 2019-12-31 | $675.00K derived: 8-K 12 month − 10-Q 9 month · filed 2021-09-08 | $37.73M derived: sum of 2 quarters · filed 2021-09-08 | $39.69M derived: sum of 3 quarters · filed 2021-09-08 | $33.57M 8-K · filed 2021-09-08 | ||||
| 2019-09-30 | $37.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $39.02M derived: sum of 2 quarters · filed 2020-11-10 | $32.89M 10-Q · filed 2020-11-10 | $32.89M 10-Q · filed 2019-11-14 | $63.28M derived: sum of 4 quarters · filed 2020-11-10 | |||
| 2019-06-30 | $1.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | -$4.16M 10-Q · filed 2020-08-11 | -$4.16M 10-Q · filed 2019-08-08 | $26.22M derived: sum of 3 quarters · filed 2020-08-11 | $33.45M derived: sum of 4 quarters · filed 2020-08-11 | |||
| 2019-03-31 | -$6.13M 10-Q · filed 2020-05-12 | -$6.13M 10-Q · filed 2019-05-09 | $24.26M derived: sum of 2 quarters · filed 2020-05-12 | $31.48M derived: sum of 3 quarters · filed 2020-05-12 | $24.33M derived: sum of 4 quarters · filed 2020-05-12 | |||
| 2018-12-31 | $30.38M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $37.61M derived: sum of 2 quarters · filed 2020-03-19 | $30.46M derived: sum of 3 quarters · filed 2020-03-19 | $37.56M 10-K · filed 2020-03-19 | $37.56M 10-K · filed 2019-03-28 | |||
| 2018-09-30 | $7.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $72.65K derived: sum of 2 quarters · filed 2019-11-14 | $7.17M 10-Q · filed 2019-11-14 | $29.00M derived: sum of 4 quarters · filed 2019-12-20 | ||||
| 2018-06-30 | -$7.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$53.96K 10-Q · filed 2019-08-08 | $21.78M derived: sum of 3 quarters · filed 2019-12-20 | |||||
| 2018-03-31 | $7.10M 10-Q · filed 2019-05-09 | $28.93M derived: sum of 2 quarters · filed 2019-12-20 | ||||||
| 2017-12-31 | $21.83M derived: 8-K 12 month − 10-Q 9 month · filed 2019-12-20 | $57.84M 8-K · filed 2019-12-20 | ||||||
| 2017-09-30 | $36.01M 10-Q · filed 2018-11-08 |